|1.||Taylor, Peter W: 3 articles (12/2015 - 07/2005)|
|2.||Luzio, J Paul: 2 articles (08/2008 - 07/2005)|
|3.||Rayner, Emma L: 1 article (12/2015)|
|4.||Negus, David: 1 article (12/2015)|
|5.||Hatch, Graham J: 1 article (12/2015)|
|6.||Vipond, Julia: 1 article (12/2015)|
|7.||Hsu, Chun-Ru: 1 article (02/2015)|
|8.||Chen, Chun-Tang: 1 article (02/2015)|
|9.||Su, Po-An: 1 article (02/2015)|
|10.||Hsieh, Pei-Fang: 1 article (02/2015)|
02/01/2015 - "Therefore, the findings of capsular type clustering among CRKP strains and effective treatment with capsule depolymerase for MDRKP infections are important for capsule-based vaccine development and therapy. "
08/01/2008 - "We used a neonatal rat pup K1 infection model to establish that prompt administration of a selective capsule depolymerase reverses the bacteraemic state and prevents death of almost all pups. "
04/01/1975 - "In addition to the spike-associated host capsule depolymerase, infection by Escherichia coli capsule bacteriophage no. 29 also induces the synthesis of a large bacteriolytic enzyme which has been purified to homogeneity. "
04/01/1975 - "As tentatively estimated from the total and the virus-associated capsule depolymerase activity in the lysates, phage 29 infection seems to produce eight to seventeen times more free than incorporated spikes."
03/01/1969 - "Analyses, by construction of phage growth curves, indicated that the polysaccharide depolymerase was synthesized by Pseudomonas aeruginosa strains B and BI after infection with phage 2. The kinetics of biosynthesis of the depolymerase were found to parallel closely the rate of formation of phage-directed virions, and alterations in the experimental conditions of infection were reflected by alterations in the production of enzyme. "
|2.||Escherichia coli Infections